首页 | 本学科首页   官方微博 | 高级检索  
     


Zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, is an agonist for GPR35
Authors:Taniguchi Yasuhito  Tonai-Kachi Hiroko  Shinjo Katsuhiro
Affiliation:Discovery Biology Research, Pfizer Global Research and Development, Nagoya Laboratories, Pfizer Inc., 5-2 Taketoyo, Aichi 470-2393, Japan.
Abstract:We found that zaprinast, a well-known cyclic guanosine monophosphate-specific phosphodiesterase inhibitor, acted as an agonist for a G protein-coupled receptor, GPR35. In our intracellular calcium mobilization assay, zaprinast activated rat GPR35 strongly (geometric mean EC(50) value of 16nM), whereas it activated human GPR35 moderately (geometric mean EC(50) value of 840nM). We also demonstrated that GPR35 acted as a Galpha(i/o)- and Galpha(16)-coupled receptor for zaprinast when heterologously expressed in human embryonic kidney 293 (HEK 293) cells. These findings will facilitate the research on GPR35 and the drug discovery of the GPR35 modulators.
Keywords:GPCR, G protein-coupled receptor   PDE, phosphodiesterase   HEK293, human embryonic kidney 293   hGPR35, human GPR35   FLAG-hGPR35, FLAG-tagged human GPR35   rGPR35, rat GPR35   DRG, dorsal root ganglion   cGMP, cyclic guanosine monophosphate
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号